NYSE:RNR - RenaissanceRe Stock Price, Forecast & News

RenaissanceRe trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNR."

RenaissanceRe declared a quarterly dividend on Wednesday, November 13th. Investors of record on Friday, December 13th will be given a dividend of $0.34 per share on Tuesday, December 31st. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Thursday, December 12th. View RenaissanceRe's Dividend History.

RenaissanceRe Holdings Ltd. (NYSE:RNR) released its quarterly earnings results on Tuesday, October, 29th. The insurance provider reported $0.29 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.01 by $0.72. The insurance provider had revenue of $704.13 million for the quarter, compared to analyst estimates of $574.66 million. RenaissanceRe had a net margin of 17.32% and a return on equity of 8.23%. The firm's revenue was up 55.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.45 EPS. View RenaissanceRe's Earnings History.

RenaissanceRe is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for RenaissanceRe.

RenaissanceRe will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

6 equities research analysts have issued 12 month price objectives for RenaissanceRe's shares. Their forecasts range from $153.00 to $220.00. On average, they anticipate RenaissanceRe's share price to reach $188.17 in the next twelve months. This suggests that the stock has a possible downside of 2.6%. View Analyst Price Targets for RenaissanceRe.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RenaissanceRe in the last year. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for RenaissanceRe.

Media headlines about RNR stock have been trending very negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RenaissanceRe earned a media sentiment score of -3.8 on InfoTrie's scale. They also assigned media stories about the insurance provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for RenaissanceRe.

RenaissanceRe saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 745,300 shares, a drop of 20.7% from the December 15th total of 939,300 shares. Based on an average trading volume of 245,200 shares, the days-to-cover ratio is currently 3.0 days. Currently, 1.7% of the shares of the stock are short sold. View RenaissanceRe's Current Options Chain.

Some companies that are related to RenaissanceRe include Alleghany (Y), Everest Re Group (RE), Reinsurance Group of America (RGA), Enstar Group (ESGR), Greenlight Capital Re (GLRE), Maiden (MHLD) and Partnerre (PRE.PH).

Based on aggregate information from My MarketBeat watchlists, some companies that other RenaissanceRe investors own include Xilinx (XLNX), Advanced Micro Devices (AMD), Home Depot (HD), Verizon Communications (VZ), Zoetis (ZTS), Arch Capital Group (ACGL), Micron Technology (MU), Keysight Technologies (KEYS), Paycom Software (PAYC) and Taiwan Semiconductor Mfg. (TSM).

RenaissanceRe's stock is owned by a number of of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.18%), Gateway Investment Advisers LLC (0.07%), United Services Automobile Association (0.03%), Louisiana State Employees Retirement System (0.02%), Sciencast Management LP (0.02%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own RenaissanceRe stock include Aditya Dutt, Henry Klehm III, Ian D Branagan, Jonathan Paradine, Kevin Odonnell, Ross Curtis and Sean G Brosnan. View Institutional Ownership Trends for RenaissanceRe.

RNR stock was sold by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Dalton Greiner Hartman Maher & Co., Assenagon Asset Management S.A., Nisa Investment Advisors LLC, State of Alaska Department of Revenue, First Hawaiian Bank, IFM Investors Pty Ltd and Calamos Advisors LLC. Company insiders that have sold RenaissanceRe company stock in the last year include Aditya Dutt, Ian D Branagan, Jonathan Paradine, Kevin Odonnell, Ross Curtis and Sean G Brosnan. View Insider Buying and Selling for RenaissanceRe.

RNR stock was acquired by a variety of institutional investors in the last quarter, including Sciencast Management LP, Polianta Ltd, Gateway Investment Advisers LLC, Clean Yield Group, Vigilant Capital Management LLC, 6 Meridian, Louisiana State Employees Retirement System and United Services Automobile Association. View Insider Buying and Selling for RenaissanceRe.

Shares of RNR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RNR stock can currently be purchased for approximately $193.22.

RenaissanceRe has a market capitalization of $8.53 billion and generates $2.07 billion in revenue each year. The insurance provider earns $227.36 million in net income (profit) each year or $9.17 on an earnings per share basis. View Additional Information About RenaissanceRe.

The official website for RenaissanceRe is http://www.renre.com/.

RenaissanceRe's mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider can be reached via phone at 441-295-4513 or via email at [email protected]